Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patients initiating medication-assisted treatment
Enrolling By Invitation
18 years - 70 years
All
Phase
N/A
225 participants needed
1 Location
Brief description of study
The purpose of this research study is to examine the impact of medications (methadone, buprenorphine, or extended-release naltrexone) used to treat opioid use disorder on the immune system — the body’s ability to fight infection. The study will try to find out how these opioid treatment medications affect immune function. This is an important question for people living with HIV infection because HIV weakens the immune system.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: HIV
-
Age: 18 years - 70 years
-
Gender: All
Updated on
19 Feb 2024.
Study ID: 833720
If you need help finding a study or have any questions, please contact us at psom-ocr@pobox.upenn.edu
